echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > JNNP: Characteristics and prognostics of stroke patients infected with COVID-19: A UK multi-center case-control study

    JNNP: Characteristics and prognostics of stroke patients infected with COVID-19: A UK multi-center case-control study

    • Last Update: 2020-12-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    COVID-19 - is a viral pneumonia characterized by dry cough, high fever, shortness of breath, loss of taste and sense of smell.
    , however, the virus that causes the disease, SARS-CoV-2, may affect the occurrence of isoemia stroke.
    this conclusion is controversial.
    the purpose of this paper is to explore which characteristics and prognosms of stroke are associated with the COVID-19 virus.
    : The study included stroke patients admitted to 13 hospitals in England and Scotland between 9 March and 5 July 2020.
    collected clinical data on 86 strokes (81 isohemia strokes and 5 cerebral hemorrhages) infected with COVID-19 at the time of the stroke.
    compared them with 1,384 strokes (1,193 isohatic strokes and 191 cerebral hemorrhages) treated in the same period, who had no evidence of COVID-19 infection (control group).
    all stroke admissions, including 37 other patients who developed COVID-19 after a stroke, were included in two logistic regression analyses to study which clinical characteristics were independently associated with COVID-19 status and inpatient mortality.
    results: Asians had a higher rate of ischemic stroke than the ischemic control group (18.8% to 6.7%, p.lt;0.0002), a high risk of multiple large vascular thase (17.9% to 8.1%, p.lt;0.03), and a higher severity (National Institutes of Health stroke scale score of 8 cents For 5 points, p-lt;0.002), it was associated with a higher level of D-D-d.01, with a more severe disability upon discharge (improved Rankin score median 4 to 3, p.lt;0.0001) and inpatient deaths (19.8 percent to 6.9 percent, p.lt;0.0001).
    recurrence of stroke in patients admitted to hospital was rare in both the case group and the control group (2.3 per cent to 1.0 per cent, NS).
    : COVID-19 may be an important regulatory factor for the onset, characteristics and prognosis of acute ischemic stroke.
    Perry RJ, Smith CJ, Roffe C, et al Features and outcomes of COVID-19 associated stroke: a UK multicentre case-control study Journal of Neurology, Neurosurgery and Psygy Published Online First: 05 November 2020. doi: 10.1136/jnnp-2020-324927MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to reproduce any media, website or person, "Source: Metz Medicine" shall be indicated at the time of authorization for reprint.
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.